Trials / Unknown
UnknownNCT03372356
Psychosocial Screening for Neuroendocrine Tumor Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Peking University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is a psychosocial screening application to usual care in a cohort of neuroendocrine tumor patients. The application involves monitoring using the NCCN Distress Thermometer(DT), Hospital Anxiety and Depression Scale(HADS), Self-Perceived Burden Scale(SPBS) and Connor-Davidson Resilience Scale(CD-RISC). These assessments will be completed at baseline, 3 months, 6 months, 12 months and 24 months. Patients will have the option of filling out questionnaires more frequently if desired.
Conditions
Timeline
- Start date
- 2017-08-09
- Primary completion
- 2019-08-09
- Completion
- 2020-08-09
- First posted
- 2017-12-13
- Last updated
- 2017-12-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03372356. Inclusion in this directory is not an endorsement.